Trazapin-15 Tablet

About Trazapin-15 Tablet

Made by Albion Laboratories Ltd., Trazapin-15 is a tablet whose active ingredient is Mirtazapine. Do not use it for any other condition without asking your doctor.

There are 20 brands of Mirtazapine listed in Bangladesh. The lowest listed price is Rapine 7.5 Tablet at ৳ 6 per unit.

What is Trazapin-15 Tablet?

Trazapin-15 15 mg tablet is a medicine made by Albion Laboratories Ltd. Trazapin-15 is an oral tablet containing 15 mg of Mirtazapine, an atypical anti-depressant. It can cause drowsiness and increased appetite. Use it only as your doctor directs.

Uses of Trazapin-15

Do not use it for any other condition without asking your doctor. Trazapin-15 is used to treat major depressive disorder in adults. It helps relieve symptoms of depression. Ask your doctor if you have questions about what it treats or how long you may need it.

How to use Trazapin-15

Trazapin-15 should be taken exactly as prescribed by the doctor. Trazapin-15 is taken by mouth. Swallow the tablet with water. If you are unsure how to take it, ask your doctor or pharmacist. Do not stop it suddenly or change the dose on your own, because your doctor needs to manage any change carefully. Do not change the dose or stop the medicine without talking to your doctor first, since stopping suddenly can cause problems.

Side effects of Trazapin-15

Seek medical help if you notice unusual changes in behaviour or mood, or any serious reaction. Like all medicines, Trazapin-15 can cause side effects. Do not drive or operate machinery if you feel drowsy. Contact your doctor promptly if you feel worse, have thoughts of harming yourself, or notice severe or troubling symptoms. Tell your doctor if side effects bother you or do not go away.

Safety and precautions

Do not drink alcohol while taking this medicine. The medicine may cause drowsiness and affect judgment and motor skills. Before taking Trazapin-15, tell your doctor if you are pregnant, plan to become pregnant, or are breastfeeding. Tell your doctor about all other medicines you use.

Frequently asked questions

Why is Trazapin-15 prescribed?

Do not use it for any other condition without asking your doctor. Trazapin-15 is used to treat major depressive disorder in adults.

How should I take Trazapin-15?

Trazapin-15 should be taken exactly as prescribed by the doctor. Trazapin-15 is taken by mouth.

Can Trazapin-15 cause side effects?

Seek medical help if you notice unusual changes in behaviour or mood, or any serious reaction. Like all medicines, Trazapin-15 can cause side effects.

Who should be careful with Trazapin-15?

Do not drink alcohol while taking this medicine. The medicine may cause drowsiness and affect judgment and motor skills.

Indications

Mirtazapine Tablets are indicated for the treatment of major depressive disorder (MDD).

Pharmacology

Pharmacodynamics: The mechanism of action of Mirtazapine as with other drugs effective in the treatment of major depressive disorder is unknown. Evidence gathered in preclinical studies suggests that Mirtazapine enhances central noradrenergic and serotonergic activity. These studies have shown that Mirtazapine acts as an antagonist at central presynaptic α2-adrenergic inhibitory autoreceptors and heteroreceptors, an action that is postulated to result in an increase in central noradrenergic and serotonergic activity. Mirtazapine is a potent antagonist of 5- HT2 and 5-HT3 receptors. Mirtazapine has no significant affinity for the 5-HT1A and 5-HT1B receptors. Mirtazapine is a potent antagonist of histamine (H1) receptors, a property that may explain its prominent sedative effects. Mirtazapine is a moderate peripheral α1-adrenergic antagonist, a property that may explain the occasional orthostatic hypotension reported in association with its use. Mirtazapine is a moderate antagonist at muscarinic receptors, a property that may explain the relatively low incidence of anticholinergic side effects associated with its use.

Pharmacokinetics: After oral administration of Mirtazapine tablets, the active constituent mirtazapine is rapidly and well-absorbed, reaching peak plasma levels after about 2 hours. Binding of mirtazapine to plasma proteins is approximately 85%. The mean half-life of elimination is 20-40 hours; (26 hours in males, 37 hours in females). The half-life of elimination is sufficient to justify once-a-day dosing. Mirtazapine displays linear pharmacokinetics within the recommended dose range. Mirtazapine is extensively metabolized and eliminated via the urine and faeces four days. Major pathways of biotransformation are demethylation and oxidation followed by conjugation.

Dosage & Administration

Adult dose: The recommended starting dose for Mirtazapine tablets is 15 mg/day, administered in a single dose, preferably in the evening or prior to sleep. The effective dose range was generally 15 to 45 mg/day and the patients not responding to the initial 15 mg dose may benefit from dose increases up to a 30 mg to maximum of 45 mg/day. Mirtazapine has an elimination half-life of approximately 20 to 40 hours; therefore, dose changes should be made at intervals of less than 1 to 2 weeks in order to allow sufficient time for the therapeutic response to a given dose.

Use in children: Use in children are not recommended to Mirtazapine.

Missed Dose: If anyone misses a dose of mirtazapine, take it as soon as remember unless it is close to when the next dose is due. If anyone missed a dose of medication and it is close to the time of next dose, skip the missed dose and should take next dose at the regularly scheduled time. One should not take double or more than prescribed dose.

Interaction

Mirtazapine has clinically significant drug-drug interactions with Monoamine Oxidase Inhibitors (MAOI) & other serotonergic drugs such as tryptophan, triptans, linezolid, serotonin reuptake inhibitors, venlafaxine, lithium, tramadol, or St. John's wort. Mirtazapine may interrupt the metabolism or activity of Carbamazepine, Phenytoin or Cimetidine. Patient should avoid Alcohol & Diazepam while taking Mirtazapine.

Contraindications

Hypersensitivity: Mirtazapine is contraindicated in patients with a known hypersensitivity to Mirtazapine or to any of the excipients.

Monoamine Oxidase Inhibitors: The concomitant use of Mirtazapine and a monoamine oxidase (MAO) inhibitor is contraindicated. Mirtazapine should not be used within 14 days of initiating or discontinuing therapy with a monoamine oxidase inhibitor (MAOI).

Side Effects

The most common side effects of Mirtazapine are dizziness, drowsiness, dry mouth, increased appetite, weight gain etc.

Pregnancy & Lactation

Pregnancy Category-C. Patients should be advised to notify their physician if they become pregnant or intend to become pregnant during Mirtazapine therapy. Patients should be advised to notify their physician if they are breastfeeding an infant.

Precautions & Warnings

Patients, their families, and their caregivers should be encouraged to be alert to the emergence of anxiety, agitation, panic attacks, insomnia, irritability, hostility, aggressiveness, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual changes in behavior, worsening of depression, and suicidal ideation, especially early during antidepressant treatment and when the dose is adjusted up or down. Patients who are to receive Mirtazapine should be warned about the risk of developing agranulocytosis. Mirtazapine may impair judgment, thinking, and particularly, motor skills, because of its prominent sedative effect. Clinically significant ALT (SGPT) elevations (≥3 times the upper limit of the normal range) may occur.

Storage Conditions

Keep away from light and moisture. Store below 30º C. Keep all medicine out of the reach of children.

Alternative brands of Mirtazapine

Other brands with the same generic name, cheapest first.

See all 20 brands

Medicine information is for reference only and is not medical advice. Always follow your doctor's prescription and check with a pharmacist.